MELANOMA RESEARCH FOUNDATION
Balance Sheet
Fiscal Year Start:
Apr 1
Assets in 2025 (Year End)
$8,283,039
Investments
41%
Other Assets
24%
Receivables (Non-Related)
19%
Cash & Equivalents
10%
Prepaid Expenses
3%
Property, Plant, & Equipment (net)
3%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2025 (Year End)
$3,344,115
Grants Payable
49%
Other Liabilities
36%
Payables & Accruals
15%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$93,261
$856,272
+818%
Receivables (Non-Related)
$3,900,412
$1,587,212
-59%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$269,601
$284,107
+5%
Investments
$1,706,411
$3,378,893
+98%
Property, Plant, & Equipment (net)
$214,562
$212,708
-1%
Other Assets
$1,086,625
$1,963,847
+81%
Total Assets
$7,270,872
$8,283,039
+14%
Liabilities
2024
2025
Change
Payables & Accruals
$416,597
$508,046
+22%
Grants Payable
$1,007,941
$1,635,193
+62%
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$1,397,433
$1,200,876
-14%
Total Liabilities
$2,821,971
$3,344,115
+19%
Net assets
2024
2025
Change
Restricted Net Assets
$3,439,731
$3,753,296
+9%
Unrestricted Net Assets
$1,009,170
$1,185,628
+17%
Net assets
2024
2025
Change
Net assets
+$4,448,901
+$4,938,924
+11%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)